iBionext

Tilak Healthcare SAS is a Paris-based company that specializes in developing mobile games intended for use as diagnostic and rehabilitation tools for chronic diseases. Founded in 2016, the company creates clinically validated mobile games that allow health professionals to monitor patients with chronic conditions, such as macula diseases, through engaging gameplay. By combining entertainment with medical monitoring, Tilak Healthcare aims to enhance patient participation in their health management and improve overall health outcomes and quality of life.

Prophesee SA, founded in 2014 and based in Paris, France, specializes in advanced machine vision sensors and systems through its innovative neuromorphic vision technology. Originally known as Chronocam SAS, the company rebranded in 2018 to reflect its pioneering approach to computer vision, which mimics the human eye and brain by detecting essential motion information rather than capturing a series of images. This unique Metavision® method enables Prophesee to achieve exceptional performance metrics, including high-speed time resolution, dynamic range, and significant reductions in data volume and power consumption. Its technology caters to a diverse range of industries, including biomedical, gaming, industrial automation, mobile devices, robotics, security, and automotive applications. Prophesee's team of over 100 engineers holds more than 50 international patents and has established a global presence with offices in cities such as Grenoble, Shanghai, Tokyo, and Silicon Valley, supported by a network of prominent investors.

Tilak Healthcare SAS is a Paris-based company that specializes in developing mobile games intended for use as diagnostic and rehabilitation tools for chronic diseases. Founded in 2016, the company creates clinically validated mobile games that allow health professionals to monitor patients with chronic conditions, such as macula diseases, through engaging gameplay. By combining entertainment with medical monitoring, Tilak Healthcare aims to enhance patient participation in their health management and improve overall health outcomes and quality of life.

GrAI Matter Labs, based in Paris with additional offices in Eindhoven and Silicon Valley, specializes in developing ultra-low power, programmable neuromorphic computing technology. The company focuses on creating brain-inspired chips that utilize spiking neural networks to enhance sensor analytics and machine learning capabilities, particularly for devices connected to the Internet of Things (IoT). These processors are designed to enable autonomous navigation for vehicles, robots, and drones, while also integrating intelligent AI into smart homes, smartphones, and wearable health monitoring devices. Founded in 2016, GrAI Matter Labs aims to optimize energy usage and improve efficiency in AI applications, providing solutions that allow machines to act and react in real time. The company seeks to redefine AI interactions, making them more intuitive and human-like.

Chronolife is focused on developing an innovative solution for continuous monitoring of multiple physiological parameters, utilizing real-time big data analysis to make health predictions. The company's proprietary algorithm, known as HOTS (Hierarchy of Event-Based Time Surfaces), is designed to transform the management of chronic conditions. Initially, Chronolife targets two significant health issues affecting many patients worldwide: Heart Failure and Epilepsy. By harnessing artificial intelligence and advanced data fusion techniques, the company aims to enhance remote monitoring and support healthcare providers in improving diagnostic accuracy and overall patient care.

Prophesee SA, founded in 2014 and based in Paris, France, specializes in advanced machine vision sensors and systems through its innovative neuromorphic vision technology. Originally known as Chronocam SAS, the company rebranded in 2018 to reflect its pioneering approach to computer vision, which mimics the human eye and brain by detecting essential motion information rather than capturing a series of images. This unique Metavision® method enables Prophesee to achieve exceptional performance metrics, including high-speed time resolution, dynamic range, and significant reductions in data volume and power consumption. Its technology caters to a diverse range of industries, including biomedical, gaming, industrial automation, mobile devices, robotics, security, and automotive applications. Prophesee's team of over 100 engineers holds more than 50 international patents and has established a global presence with offices in cities such as Grenoble, Shanghai, Tokyo, and Silicon Valley, supported by a network of prominent investors.

GrAI Matter Labs, based in Paris with additional offices in Eindhoven and Silicon Valley, specializes in developing ultra-low power, programmable neuromorphic computing technology. The company focuses on creating brain-inspired chips that utilize spiking neural networks to enhance sensor analytics and machine learning capabilities, particularly for devices connected to the Internet of Things (IoT). These processors are designed to enable autonomous navigation for vehicles, robots, and drones, while also integrating intelligent AI into smart homes, smartphones, and wearable health monitoring devices. Founded in 2016, GrAI Matter Labs aims to optimize energy usage and improve efficiency in AI applications, providing solutions that allow machines to act and react in real time. The company seeks to redefine AI interactions, making them more intuitive and human-like.

BrainEver focuses on developing innovative therapeutics for neurodegenerative disorders, rooted in the research of Alain Prochiantz and colleagues on brain development and physiology. The company explores the potential of homeoproteins, which are known to regulate neuronal functions throughout life, to enhance the physiological resistance and activity of surviving neurons in patients. This approach aims to improve clinical symptoms in conditions such as Parkinson's disease and amyotrophic lateral sclerosis (ALS). The company is advancing its lead candidate, Engrailed 1 (BREN01), while also working on a pipeline of additional drug candidates targeting other neurodegenerative diseases, including Huntington's disease and optic neuropathies. By developing these novel therapeutics, BrainEver aims to provide effective treatment options for healthcare practitioners and patients affected by these challenging conditions.

Prophesee SA, founded in 2014 and based in Paris, France, specializes in advanced machine vision sensors and systems through its innovative neuromorphic vision technology. Originally known as Chronocam SAS, the company rebranded in 2018 to reflect its pioneering approach to computer vision, which mimics the human eye and brain by detecting essential motion information rather than capturing a series of images. This unique Metavision® method enables Prophesee to achieve exceptional performance metrics, including high-speed time resolution, dynamic range, and significant reductions in data volume and power consumption. Its technology caters to a diverse range of industries, including biomedical, gaming, industrial automation, mobile devices, robotics, security, and automotive applications. Prophesee's team of over 100 engineers holds more than 50 international patents and has established a global presence with offices in cities such as Grenoble, Shanghai, Tokyo, and Silicon Valley, supported by a network of prominent investors.

Tilak Healthcare SAS is a Paris-based company that specializes in developing mobile games intended for use as diagnostic and rehabilitation tools for chronic diseases. Founded in 2016, the company creates clinically validated mobile games that allow health professionals to monitor patients with chronic conditions, such as macula diseases, through engaging gameplay. By combining entertainment with medical monitoring, Tilak Healthcare aims to enhance patient participation in their health management and improve overall health outcomes and quality of life.

Prophesee SA, founded in 2014 and based in Paris, France, specializes in advanced machine vision sensors and systems through its innovative neuromorphic vision technology. Originally known as Chronocam SAS, the company rebranded in 2018 to reflect its pioneering approach to computer vision, which mimics the human eye and brain by detecting essential motion information rather than capturing a series of images. This unique Metavision® method enables Prophesee to achieve exceptional performance metrics, including high-speed time resolution, dynamic range, and significant reductions in data volume and power consumption. Its technology caters to a diverse range of industries, including biomedical, gaming, industrial automation, mobile devices, robotics, security, and automotive applications. Prophesee's team of over 100 engineers holds more than 50 international patents and has established a global presence with offices in cities such as Grenoble, Shanghai, Tokyo, and Silicon Valley, supported by a network of prominent investors.